Victory Capital Management Inc Ngm Biopharmaceuticals Inc Transaction History

Victory Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$11.97 - $23.47 $473,102 - $927,628	-39,524 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$10.0 - $19.51 $38,240 - $74,606	-3,824 Reduced 8.82%	39,524 $487,000
Q4 2019 Feb 06, 2020	BUY	$9.97 - $20.28 $37,178 - $75,624	3,729 Added 9.41%	43,348 $802,000
Q4 2019 Feb 04, 2020	SELL	$9.97 - $20.28 $2.77 Million - $5.63 Million	-277,697 Reduced 87.51%	39,619 $641,000
Q3 2019 Nov 12, 2019	BUY	$13.09 - $18.19 $2.48 Million - $3.45 Million	189,566 Added 148.39%	317,316 $4.4 Million
Q2 2019 Aug 15, 2019	BUY	$12.56 - $16.6 $1.6 Million - $2.12 Million	127,750 New	127,750 $1.87 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.